Echocardiography

Syntermed, Inc. is a medical software company specializing in advanced diagnostic imaging analysis tools for nuclear cardiology, brain imaging, and PSMA PET/CT scanning. The company develops FDA-cleared, ISO 13485-certified software solutions that enhance clinical value and diagnostic accuracy across multiple imaging modalities. Primary product lines include the Cardiac Toolbox (eCTB), a comprehensive multi-modality platform for SPECT, PET, calcium scoring, myocardial blood flow, and strain analysis with integrated reporting and remote reading capabilities; NeuroQ 4, brain imaging analysis software for FDG-PET, Amyloid, SPECT, and DatScan imaging; and aPROMISE, a deep learning application for quantitative PSMA PET/CT assessment. Syntermed Live enables remote, cloud-based reading and reporting for nuclear cardiology studies. The company's Smart Scores technology provides automated quantitative segmental analysis with natural language report generation and physician decision support. Products are designed for nuclear medicine departments, cardiology practices, and neuroimaging centers. Syntermed has been the exclusive licensee of the Emory Cardiac Toolbox for over 25 years and recently acquired the intellectual property rights. The company maintains FDA Quality System Records and Pre-Market Notification (510(k)) clearance, along with European Union CE Mark (ISO 13485:2016) certification. All medical devices comply with applicable regulatory frameworks for diagnostic imaging software in the United States and European markets.

CS Medical LLC, founded in 2003, is a medical device manufacturer specializing in automated cleaning and high-level disinfection systems for ultrasound probes. The company develops evidence-based solutions for probe reprocessing across general ultrasound (transvaginal, transrectal, surface probes), transesophageal echocardiogram (TEE), and related diagnostic applications. CS Medical's core product portfolio includes the Ethos® automated ultrasound probe cleaner-disinfector, TEEClean® automated TEE probe cleaner-disinfector, and the TD 100® and TD 200® rapid TEE disinfectors. The company manufactures and markets complementary products including probe storage cabinets (CleanShield®), enzymatic cleaners (TEEZyme®), probe covers (PullUp™), transportation cases (TPorter®), distal tip protectors (TDefender™), high-level disinfectants, and accessories. CS Medical's systems are compatible with major ultrasound manufacturers including Philips, Samsung, and Siemens. The company emphasizes standardized, automated workflows to improve reprocessing quality, reduce variations, control costs, and minimize patient risk from improper probe handling. Products support infection control compliance and healthcare operational efficiency across cardiology, obstetrics/gynecology, general diagnostic imaging, and surgical settings. CS Medical serves hospital labs, imaging centers, and operating room departments.

Medtronic is a global healthcare technology leader serving 79+ million patients across diagnostic imaging, surgical and operating room equipment, intensive care, specialty medical, and homecare sectors. The company manufactures and distributes a comprehensive portfolio spanning cardiac rhythm and diagnostics systems, pacemakers, implantable cardioverter-defibrillators, deep brain stimulation devices, robotic surgery platforms, ventilators, anesthesia machines, infusion pumps, continuous glucose monitoring systems, insulin pumps, endoscopic and surgical navigation systems, and wound closure products. Recent FDA clearances include the Stealth AXiS surgical system for spine surgery and pulsed field ablation (PFA) technologies for atrial fibrillation treatment. Medtronic serves hospitals, surgical centers, critical care units, interventional labs, and home care settings through product lines in cardiac, vascular, neuromodulation, minimally invasive surgery, respiratory, and diabetes management. The company conducts 170+ active clinical trials, invests $2.7B annually in R&D, and holds FDA 510(k) clearances, CE marks, and ISO 13485 certification. Manufacturing and distribution capabilities span North America, Europe, and international markets with customer support available 24/7.

Siemens Healthineers AG is a global leader in medical technology specializing in diagnostic imaging, laboratory diagnostics, precision therapy, and advanced healthcare solutions. Founded in 1847 and spun off as an independent entity in 2015, the company employs approximately 74,000 people worldwide and invests over €1 billion annually in research and development. The company's portfolio encompasses advanced imaging technologies including PET-CT scanners, MRI systems, and wireless ultrasound transducers, alongside laboratory diagnostics platforms conducting over 9 billion tests annually. Siemens Healthineers is particularly renowned for precision therapy innovations in oncology, featuring image-guided treatments and radiation therapy solutions. The company operates in more than 70 countries, with solutions trusted by 90% of leading hospitals globally. Its AI-driven diagnostic software and digital tools optimize clinical workflows and support early disease detection, particularly for lung and prostate cancer screening. The company maintains strategic partnerships with major healthcare providers and research institutions to enhance innovation and patient outcomes.

Medis Medical Imaging Systems is a Netherlands-based software company founded in 1989 as a spin-off from Leiden University Medical Centre. Specializing in vendor-independent, AI-powered cardiovascular image analysis software, Medis develops solutions for quantitative analysis across multiple imaging modalities including X-ray, CT, MRI, ultrasound, and intravascular imaging (IVUS/OCT). The company's flagship products include Medis QFR® (coronary physiology analysis via deep learning), Medis Suite MR (cardiac MRI post-processing), Medis Suite CT (cardiovascular CT quantification), Medis Suite XA (coronary and ventricular X-ray analysis), Medis Suite Ultrasound (cardiac deformation analysis), and Intravascular (IVUS/OCT post-processing). With ~126 employees globally and operations across 27+ countries, Medis serves hospitals, imaging centers, and research institutions. The company holds multiple patents and certifications; Medis QFR® has Class I recommendations in the 2024 ESC Guidelines for chronic coronary syndrome management. Medis emphasizes scientific rigor, clinical workflow efficiency, and user-oriented design in supporting cardiologists, radiologists, and researchers.

Jiangsu Tingsn Technology Co., Ltd. is a medical device manufacturer specializing in intracardiac ultrasound (ICE) imaging and interventional cardiology solutions. The company develops and commercializes advanced ultrasound systems for cardiac electrophysiology and structural heart disease applications, including 2D intracardiac ultrasound imaging catheters (TINGSN Sonic Eyes 10 series, NMPA-approved), portable color ultrasound diagnostic systems (TINGSN FINDERS 1), and pipeline products including 4D ICE systems, 3D ultrasound mapping systems, and ultrasound ablation energy systems. The company's technology integrates imaging, mapping, and ablation capabilities to enable minimally invasive cardiac interventions.

Epsilon Elektronik Sanayi ve Ticaret A.Ş. is a Turkish medical equipment distributor and solution provider established in 1993, based in Istanbul with over 30 years of specialization in nuclear medicine, radiation oncology, and medical imaging. The company holds ISO 13485:2016 and ISO 9001:2015 certifications and serves as the authorized distributor for leading international manufacturers including IBA Dosimetry, Mirion/Capintec, QFix, Modus QA, CLERAD, and LabLogic. Epsilon offers comprehensive services including turnkey nuclear medicine center project management, technical support, calibration, and quality control testing for dose calibrators and gamma cameras. The company develops proprietary innovations such as Ge-68 calibration sources, I-125 tumor localization seed sources, and Co-57 flood sources for SPECT/PET imaging systems. Additional product portfolio includes radiation protection equipment, lead shielding products, water phantoms, patient positioning and immobilization devices, dosimetry systems, and decontamination solutions. Epsilon engages in international trade, exporting to the Netherlands, China, and importing from the United States and Russia, positioning itself as a comprehensive B2B solution partner for hospitals, imaging centers, and radiation therapy facilities across Europe and Asia.

NeoSoft, LLC is a cardiac MRI software company headquartered in Pewaukee, Wisconsin, founded in 2004 by Dr. Steven D. Wolff. The company specializes in advanced cardiovascular post-processing software that streamlines cardiac MRI analysis and reporting. The flagship product, suiteHEART®, is a vendor-agnostic software suite featuring zero-click preprocessing, semi-automated segmentation, and an intuitive interface designed specifically for cardiac MR workflows. The platform significantly reduces analysis time (reportedly up to 80–90% per clinical feedback) and includes comprehensive analysis modules for function, flow, myocardial evaluation, T1/T2 mapping, perfusion, strain, 4D flow visualization, and specialized assessments. suiteHEART® is FDA-cleared (510k #K130228), CE-marked, and registered in multiple international markets including Canada, EU, Australia, Brazil, and others. The company offers flexible licensing options (unlimited or per-case) to accommodate diverse institutional needs and serves radiology departments, cardiac imaging centers, and medical institutions globally.

Susquehanna Micro Inc. is a Pennsylvania-based medical device distributor and authorized North American dealer for Acutronic high-frequency jet ventilators. The company specializes in the sales, service, and repair of respiratory and pulmonary function testing equipment, serving hospitals, ICUs, family practices, and sports rehabilitation centers. With over 20 years of experience, Susquehanna Micro offers comprehensive respiratory care solutions including ventilation systems (Monsoon III, LSP Autovent), pulmonary function testing equipment from CosMed, metabolic testing systems, patient monitoring devices (oximeters from Masimo, Nonin, Venni), airway management tools (InfantView neonatal video-intubation device), and oxygen delivery accessories. The company partners with leading manufacturers such as Acutronic, CosMed, BioMed Devices, Precision Medical, NDD, and uVida. Susquehanna Micro provides 24/7 emergency service support for ventilators and life support equipment throughout North America. As a veteran and female-owned corporation, the company emphasizes unmatched service, calibration, maintenance, and repair support for critical respiratory care infrastructure.

TeraRecon, Inc. is a healthcare software company specializing in AI-powered advanced medical imaging visualization and enterprise image management solutions. The company delivers SaaS-based platforms—TeraRecon AV (registered as Intuition globally) and TeraRecon DETECT—that combine advanced 3D visualization with AI-driven automation to enhance diagnostic precision and clinical workflow efficiency. Products support radiology, cardiology, neurology, vascular surgery, and oncology applications with features including medical image viewing, AI biomarker detection, real-time decision support, and enterprise imaging consolidation. Founded in 1997 and based in Durham, North Carolina, TeraRecon serves approximately 1,900 clinical sites globally with ~195-244 employees and ~$41M annual revenue. The platform emphasizes interoperability, enabling integration with existing hospital imaging systems while automating routine interpretation tasks and reducing clinician time-to-diagnosis.

ZEISS Group is a leading German multinational optical and optoelectronics company founded in 1846, headquartered in Oberkochen with approximately 30 production and 25 development sites across nearly 50 countries. The company specializes in precision optics, optical systems, and advanced medical technologies. In medical technology, ZEISS manufactures diagnostic imaging systems, surgical microscopes, and ophthalmic devices including diagnostic systems and intraocular lenses through Carl Zeiss Meditec AG. Its research microscopy division develops optical, electron, and ion microscopes for life sciences and materials research. ZEISS also supplies semiconductor manufacturing equipment and industrial metrology solutions. The company demonstrates expertise in AI-enhanced imaging, digital health solutions, and innovation across healthcare, industrial, and research sectors. With consolidated earnings of approximately €2 billion annually, ZEISS maintains a commitment to precision engineering and technological advancement across multiple high-value markets.

EchoNous is a medical technology company specializing in AI-powered, ultraportable point-of-care ultrasound (POCUS) systems that enhance bedside diagnostics across clinical settings. Founded in 2016 and headquartered in Redmond, Washington, the company integrates advanced ultrasound hardware with proprietary deep learning algorithms to deliver cart-based image quality in portable form factors. The flagship Kosmos platform features real-time AI-driven guidance for probe positioning, automated cardiac analysis, image quality grading, and advanced Doppler capabilities (Pulsed Wave, Continuous Wave, and Tissue Doppler Imaging). Product offerings include Kosmos Portable Ultrasound, Kosmos Mobile (iPad-based), Kosmos Plus (fully featured configuration with stand), Kosmos Bladder (AI-assisted bladder volume calculation), and Kosmos EDU (educational platform for novice users). EchoNous serves critical care, emergency medicine, cardiology, nephrology, vascular access, anesthesiology, and primary care settings. The company manufactures Kosmos in the USA, offers HIPAA and SOC2 compliance, and partners with Us2.ai, 19 Labs, and Trice Imaging to deliver comprehensive software solutions and telehealth capabilities.

UltraSight is an Israeli digital health company specializing in AI-powered cardiac ultrasound imaging software. The platform provides real-time guidance and quality assessment to enable healthcare professionals of any sonography proficiency level to consistently perform high-quality cardiac ultrasound acquisitions at the point of care—in clinics, community hospitals, ambulances, and remote/rural areas. The software integrates with ultrasound devices (including Philips Lumify) and complies with healthcare standards (HL7, DICOM). UltraSight has achieved FDA clearance and CE Mark certification. The solution addresses critical clinical needs in emergency medicine, out-of-hospital care, critical care monitoring, and resource-limited settings, democratizing access to cardiac imaging while improving diagnostic accuracy and reducing repeat procedures. Clinical evidence demonstrates that novice users achieve diagnostic-quality images approaching expert sonographer performance following minimal training.

Alpinion Medical Systems is a South Korea-based manufacturer of diagnostic and therapeutic ultrasound systems founded in 2007. The company specializes in designing and manufacturing a comprehensive ultrasound portfolio comprising 11 diagnostic ultrasound systems, six types of proprietary transducers utilizing single crystal technology, and the ALPIUS 900 HIFU (High-Intensity Focused Ultrasound) platform for therapeutic applications. Its diagnostic X-CUBE series delivers advanced imaging solutions tailored for internal medicine, obstetrics/gynecology, and cardiology applications. The ALPIUS 900 platform provides non-invasive treatment options for uterine fibroids and adenomyosis. Alpinion integrates AI-powered intelligent technologies throughout the ultrasound workflow—from screening and early detection to diagnosis and reporting—to enhance clinical efficiency and diagnostic confidence. The company maintains a global presence with offices in the USA, Germany, and China, and operates through a network of distributors across 80+ countries.

MIM Software Inc., a GE HealthCare company founded in 2003, is a vendor-neutral medical imaging software provider serving over 3,300 healthcare organizations globally, including 90% of the world's top 50 hospitals. The company specializes in imaging analysis and clinical workflow software for radiation oncology, nuclear medicine, cardiology, theranostics, neurology, and urology. Key offerings include MIM Encore™ for digital imaging and workflow solutions, AI Auto-Contouring tools for treatment planning, MIM Symphony Dx™ for prostate MRI visualization and analysis, MIM LesionID™ Pro for automated tumor burden analysis, and MIM ComboTherapy™ GYN HDR/EBRT for combined gynecologic cancer treatment planning. Solutions emphasize standardization, automation, and AI-driven enhancements to improve clinical efficiency, patient safety, and precision care delivery across oncology, diagnostic imaging, and specialty medicine applications.

TransducerWorks, founded in 2007 and part of the Vermon Group since 2018, is a U.S.-based manufacturer of custom ultrasound transducers, arrays, and probes for medical and industrial applications. The company employs 100+ engineers and manufacturing experts in Pennsylvania and delivers high-performance solutions for OEMs in diagnostics, point-of-care, interventional, veterinary, and innovation-driven medical sectors. TransducerWorks specializes in medical diagnostic probes for radiology, cardiovascular, and OB/GYN imaging, including portable and handheld (POCUS) systems for emergency and ICU use. The company also develops therapeutic ultrasound solutions for neurostimulation, neuromodulation, and targeted drug delivery, spanning focused (HIFU, LIFU) and unfocused (LIPUS) applications at frequencies above 500 kHz. Veterinary ultrasound offerings cover all species with rugged, cost-effective designs compatible with portable or cart systems. TransducerWorks operates under ISO 13485 certification with FDA compliance, RoHS and REACH adherence, ensuring precision, traceability, and regulatory alignment for medical device manufacturers and research institutions.

Bracco is a global leader in diagnostic imaging established in 1927 in Milan, Italy, with operations in over 100 countries and approximately €2.0 billion in annual revenue. The company operates three main business units: Bracco Imaging, ACIST Medical Systems, and Centro Diagnostico Italiano (CDI). Bracco specializes in contrast agents and imaging solutions for diagnostic radiology, including gadolinium-based contrast agents for MRI, iodamide and iopamidol for X-ray and CT imaging, barium-based products for radiography, and sulfur hexafluoride microbubbles for ultrasound applications. The company manufactures automated injection systems and advanced medical devices for cardiovascular imaging through its ACIST subsidiary, offering solutions in interventional cardiology. Bracco also develops specialized imaging technologies in nuclear oncology and fluorescence image-guided surgery. With 11 innovation centers worldwide and 8% of turnover reinvested in R&D, the company maintains over 2,500 active patents and is recognized for commitment to research, sustainability, and clinical excellence across diagnostic imaging modalities.

Aidoc is a healthcare AI software company founded in 2016, providing clinical decision support solutions built on its proprietary aiOS™ platform. The company delivers AI-powered medical imaging analysis and clinical intelligence tools across radiology, cardiology, neurovascular, and vascular care specialties. Aidoc's algorithms automatically analyze medical imaging (primarily CT scans) to detect acute pathologies, identify incidental findings, and prioritize critical cases for rapid clinical intervention. The platform integrates with hospital workflows to improve notification time-to-treatment, enhance care team coordination, and optimize patient management across departments. Serving over 1,600 medical centers globally and analyzing imaging for approximately 45 million patients annually, Aidoc enables healthcare systems to cover approximately 75% of their patient populations with AI-assisted clinical decision support. Key clinical applications include stroke detection and door-to-puncture time reduction, pulmonary embolism prioritization, cardiac disease measurement, and vascular pathology management.

EchoIQ Limited develops AI-driven clinical decision support software for echocardiography, specifically designed to optimize structural heart damage assessment. The company's flagship platform, EchoSolv AS, leverages measurement-based AI (not image analysis) to deliver rapid, consistent insights from routine echocardiographic measurements. The platform has been developed using one of the world's largest echocardiographic datasets (200+ million measurements) and is FDA-cleared for clinical use. EchoSolv AS is designed to complement clinician review and help identify patients at risk for structural heart conditions such as aortic stenosis, delivering results in seconds at the point of clinical decision. The solution integrates into existing cardiology workflows with minimal disruption, enhancing consistency, efficiency, and throughput in echo laboratories. The company markets to cardiology departments, echo labs, and healthcare systems seeking to standardize measurements and improve diagnostic precision while maintaining clinician control and judgment.

Alpinion Medical Systems is a South Korean manufacturer of diagnostic ultrasound systems and therapeutic ultrasound technologies. The company designs and manufactures a comprehensive portfolio of ultrasound equipment spanning general imaging, obstetrics and gynecology, cardiovascular diagnostics, and musculoskeletal applications. Core product lines include the X-CUBE series of diagnostic ultrasound systems (including X-CUBE i9 and X-CUBE 90 Elite), which integrate AI-assisted technologies for workflow optimization and clinical decision support across screening, detection, and reporting stages. Alpinion also develops high-intensity focused ultrasound (HIFU) systems for therapeutic and research applications, along with proprietary transducers manufactured in-house. The company operates with R&D capabilities and maintains branch offices in the USA, Germany, and China, with distribution in over 80 countries globally. Alpinion is a subsidiary of Iljin Group, a South Korean conglomerate. The organization focuses on delivering clinically validated ultrasound solutions to healthcare providers in diagnostic imaging, cardiology, obstetrics, and musculoskeletal medicine. Regulatory certifications and specific FDA or CE mark status are not detailed in available web content but are typical for products marketed in North American and European markets.

Visura Technologies, Inc. is a medical device company specializing in visualization technology for minimally invasive cardiology and anesthesia procedures. The company manufactures TEECAD®, the world's first FDA-cleared disposable camera designed to integrate with transesophageal echocardiogram (TEE) probes. TEECAD provides real-time visualization of the esophageal inlet during intubation, enabling physicians to achieve more efficient and effective probe placement during TEE procedures. The device is intended for use in operating rooms, intensive care units, and cardiac catheterization labs where TEE is performed. Visura's technology addresses a clinical gap in procedural visualization, offering a single-use, camera-integrated solution that eliminates cross-contamination concerns and simplifies workflow integration with existing TEE equipment. The company is based in Bloomington, Minnesota, and is led by founder and Chief Medical Officer David Marmor, MD. The board includes experienced healthcare executives and investors, positioning the company for growth in the cardiac imaging and anesthesia equipment markets. As an FDA-cleared medical device manufacturer, Visura demonstrates commitment to regulatory compliance and clinical safety standards required for devices used in critical care settings.

Transonic Systems Inc. is a medical device manufacturer specializing in ultrasonic Transit-Time blood flow measurement technologies. Founded in 1983 and headquartered in Ithaca, New York, the company provides precision measurement solutions for surgical, clinical, research, and OEM applications. Transonic's product portfolio includes intraoperative blood flow meters for cardiothoracic, cerebrovascular, transplant, and microvascular surgery; hemodialysis flow monitors for vascular access assessment; mechanical circulatory support flow measurement systems for ECMO and cardiopulmonary bypass; tubing flowsensors for biomedical research and device manufacturing; and comprehensive life science research instrumentation for blood flow, pressure, and cardiac output measurement. The company also offers Transonic-Inside™, a customizable OEM integration program enabling medical device developers to embed advanced flow measurement capabilities into their platforms. With global operations across the US, Europe, Asia, Japan, and Taiwan, Transonic serves hospitals, research institutions, and medical device manufacturers seeking gold-standard accuracy and validation-backed measurement solutions.

Freeland Systems develops cloud-based clinical imaging informatics software and PACS (Picture Archiving and Communication Systems) solutions. The company's core product line is AccessPoint, a suite of connected clinical solutions designed for enterprise imaging management, remote study access, and AI-guided diagnostic reporting. AccessPoint offerings include: Clinical Imaging Cloud (on-demand study access and intelligent reporting), UltraView (zero-footprint multi-modality diagnostic workspace with AI-guided reporting), and GO (direct-to-cloud gateway for ultrasound, digital X-ray, and imaging device integration). The platform supports structured workflows, automated data transfer, custom templates, and secure virtual study sharing among clinicians and referring physicians. Freeland Systems specializes in cardiology and vascular imaging informatics, providing comprehensive cardiac imaging analysis and study documentation capabilities. The company serves academic institutions, hospitals, imaging centers, and clinical practices. Solutions emphasize cloud-based accessibility, interoperability with EHR systems and imaging devices, physician workflow optimization, and remote collaboration. No specific FDA clearances or certifications mentioned in available content.

Wisonic Medical Technology (华声医疗) is a China-headquartered medical device company specializing in ultrasound systems and cloud-enabled clinical solutions. The company designs and manufactures specialty ultrasound platforms across multiple clinical domains: general bedside ultrasound, obstetric/gynecological ultrasound, anesthesia and pain management ultrasound, critical care ultrasound, musculoskeletal/rehabilitation ultrasound, veterinary ultrasound, and fetal monitoring systems. Primary product lines include Lotus (screening ultrasound), Polaris/Labat/Navi (anesthesia/pain), Clivia/Clover (bedside), Sunflower/Carnation (critical care), Piloter (rehabilitation), Apus (veterinary), and Lavender/Mugwort (patient monitoring/bedside monitors). The company also develops cloud-based telemedicine and remote consultation capabilities, PACS software (华声云PACS), intelligent quality control systems for ultrasound imaging, and data asset services. Wisonic holds CFDA (China FDA) approvals for multiple products and maintains ISO 13485 certification. The company operates a global distribution and service network spanning 100+ countries with presence in 3,000+ hospitals. Wisonic maintains R&D partnerships with leading universities (Tsinghua, Tongji, Michigan State) and has received national high-tech enterprise status and specialist/champion manufacturing designation from Chinese authorities. Training and clinical education are core competencies, with annual workshops and the "Dandelion Academy" cloud learning platform serving 120,000+ trained clinicians globally.

ScImage is a healthcare enterprise imaging solutions provider founded in 1993, headquartered in Los Altos, California. The company specializes in cloud-centric PACS (Picture Archiving and Communication Systems) and enterprise medical imaging platforms. ScImage's flagship product, PICOM365, is a unified medical image management software designed to streamline diagnostic imaging workflows across multiple specialties including cardiology, radiology, vascular imaging, and ophthalmology. PICOM365 offers flexible deployment options—cloud, on-premises, or hybrid—and supports secure image exchange, integrated AI analytics, and seamless EHR interoperability. The platform scales from solo practices to multi-hospital health systems and includes specialty-specific tools for cardiology (CVIS), vascular imaging, and enterprise imaging. With approximately 86-100 employees and $21.5 million in annual revenue, ScImage partners with Canon Medical Systems and provides 24/7 US-based customer support.

B. Braun Interventional Systems Inc., a subsidiary of the B. Braun Group, designs and manufactures innovative medical devices for interventional procedures, with focus on cardiology and vascular interventions. The company develops solutions across angioplasty and valvuloplasty catheters, congenital and structural heart devices, percutaneous drainage systems, vena cava filters, vascular access devices, and interventional accessories. Products are engineered in collaboration with physicians, technologists, and nurses to enhance patient outcomes, procedural safety, efficiency, and precision. The company operates from its Bethlehem, Pennsylvania facility and serves hospital catheterization laboratories, interventional radiology departments, and specialty centers. Notable product lines include the COMPASS™ Guiding Introducer Sheath, Occlutech® ASD Occluder, NuDEL™ CP Stent® Delivery System, ŌNŌ™ Retrieval Device, and Accel® Drainage Catheter Sets. B. Braun Interventional Systems maintains 24/7 customer support and emergency on-call services. The company holds national contracts and is committed to compliance and ethical business practices within the medical device industry.

MGC Diagnostics Corporation is a global medical technology company specializing in non-invasive cardiorespiratory diagnostic products and systems. Founded in 1986 and headquartered in Saint Paul, Minnesota, the company designs and manufactures advanced diagnostic equipment for measuring respiratory function, gas exchange, and cardiovascular performance. Key product lines include pulmonary function testing systems, cardiopulmonary exercise testing (CPET/CPX) equipment, FeNO (fractional exhaled nitric oxide) monitoring systems, indirect calorimetry devices, stress testing systems, and treadmills. The company serves hospitals, clinics, sports medicine facilities, and pulmonary rehabilitation centers with integrated solutions for disease detection, chronic disease monitoring, and patient wellness across cardiorespiratory health. MGC Diagnostics provides comprehensive support including technical assistance, training programs, clinical research solutions, and preventive maintenance services.

PARICO Medical LLC manufactures professional-grade treatment and diagnostic tables engineered for clinics, physiotherapy centers, sports medicine practices, and diagnostic imaging environments. The company specializes in electric hi-lo treatment tables (iPRO and BASE series) with multi-angle adjustability, power imaging tables for ultrasound and interventional procedures, and height-adjustable clinical stools. All equipment features TIMOTION premium motors, ISO 13485 manufacturing certification, CE and FDA approval, and includes 5-year warranties. PARICO emphasizes cost-effective pricing, US-based distribution, responsive after-sales support, and parts availability. The company serves clinics seeking reliable, ergonomic medical furniture without premium pricing.

Medviso is a Swedish medical technology company specializing in clinical software solutions for quantitative cardiac imaging analysis. The company develops advanced tools for cardiac MRI and CT image segmentation, analysis, and quantification, alongside 3D printing and medical modeling capabilities. Medviso's flagship product, Segment, is a comprehensive cardiac MR/CT analysis platform offering AI-driven algorithms for strain analysis, 4D flow analysis, and automated segmentation. The company also provides freely available research-grade software solutions for academic institutions and researchers worldwide. With close partnerships with Lund Cardiac MR Group and Skåne University Hospital, Medviso bridges clinical routine and cutting-edge research, delivering validated tools for both clinical workflows and preclinical animal imaging applications.

Harvard Bioscience Inc is a holding company and distributor of laboratory and research equipment serving academic institutions, contract research organizations (CROs), pharmaceutical, and biotech companies. The company operates through multiple subsidiary brands including Data Sciences International (DSI), BTX Electroporation Systems, Multi Channel Systems (MCS), Biochrom, HEKA, Harvard Apparatus, Panlab, Warner Instruments, CMA Microdialysis, and Hugo Sachs Elektronik. Product portfolio encompasses electrophysiology systems (patch clamp amplifiers, multielectrode arrays, Ussing chambers), spectrophotometers and colorimeters (Ultrospec series, Biowave), amino acid analyzers, telemetry and behavioral monitoring systems, electroporation devices, and isolated organ perfusion systems. The company serves discovery, production, and regulatory compliance workflows for life-saving therapeutic development. Products include the INCUB8 multiwell MEA system for optical and electrophysiological recording, HEKA EPC 10 USB 3.0 patch clamp amplifier, IntraCell laser-based optoporation system, VivaMARS activity monitoring platform, Ponemah software (GLP and 21 CFR Part 11 compliant), continuous glucose telemetry for rodents, and various UV-Vis spectrophotometric instruments. The company actively participates in major scientific conferences including SfN, APS, ECS, and ISSCR, and maintains active engagement in neuroscience, cardiac, and translational research communities.

CHISON Medical Technologies Co., Ltd. is a global manufacturer of ultrasound diagnostic systems founded in 1996. The company designs and manufactures cart-based, portable, handheld, and B&W ultrasound systems serving radiology, cardiovascular, women's health, general imaging, point-of-care, and primary care specialties. Product lines include SonoPort, SonoMax, XBit, CBit, and QBit cart-based systems; SonoAir, SonoBook, EBit, ECO, and SonoTouch portable platforms; and SonoEye handheld devices. CHISON maintains a global R&D center integrating resources from China and the US, with approximately 700 intellectual properties registered across China, EU, and US markets. The company is certified by FDA, CE, CMD, CSA, and KFDA. CHISON operates in over 100 countries and is listed on China's STAR Market, representing the only ultrasound manufacturer with this distinction. The company emphasizes independent innovation and advanced image analysis algorithms. Applications include vascular imaging, musculoskeletal assessment, OB/GYN screening, emergency medicine, and veterinary diagnostics. Manufacturing and customer support services are headquartered in Wuxi, Jiangsu, China, with a US subsidiary office in Bellevue, Washington.

AISAP LTD develops FDA-cleared AI diagnostic software for point-of-care ultrasound (POCUS) systems, with a primary focus on cardiac imaging and structural heart disease detection. The company's flagship product, POCUS-OS™, is an all-in-one AI operating system that integrates with existing ultrasound devices from major manufacturers (GE, Philips, Siemens, Samsung, SonoSite, Butterfly, Wisonic, and others) to deliver expert-level cardiac measurements and automated diagnosis at the bedside. The platform includes AI-powered interpretation, structured reporting (reducing reporting time by up to 90%), cloud-based or on-premise PACS functionality, and seamless EMR integration. Clinical applications include early detection of aortic stenosis, mitral regurgitation, tricuspid regurgitation, right ventricular dysfunction, pericardial effusion, and pulmonary embolism risk assessment. The company serves hospitals, health systems, clinics, and emergency departments globally. Research partnerships include Stanford, Mayo Clinic, Inova, Jefferson Health, and others. AISAP emphasizes workflow efficiency, reduced length of stay, improved diagnostic accuracy for non-cardiologists, and increased billing capture (up to 95% billable encounters). The platform operates on flexible deployment (on-premise to cloud architecture) and includes QA/accreditation tools for quality standardization. FDA clearance status confirmed on website; CE and ISO compliance inferred from regulatory context but not explicitly stated.

Fukuda Denshi USA, Inc. is the North American subsidiary of Fukuda Denshi, a global manufacturer of integrated patient monitoring, diagnostic cardiology, and digital health solutions for acute care, general care, and ambulatory settings. The company specializes in bedside and central station patient monitoring systems, including multiparameter monitors (vital signs, ECG, blood pressure, oxygen saturation), portable monitoring devices, and diagnostic cardiology/vascular testing equipment (ECG, stress testing systems, echocardiography systems). Fukuda's product portfolio includes the DS-1800 Central Station and LXN-1000 series portable monitors designed for flexible deployment across clinical workflows. The company also offers interoperability and digital health solutions that integrate with existing hospital information systems and EHRs, emphasizing configurable, seamless integration without requiring workflow changes. Fukuda maintains a support infrastructure including technical support, training, and field service capabilities. Products are designed for hospital acute care units, ICUs, general care floors, and outpatient diagnostic labs. The company emphasizes ease of use, installation simplicity, and cost-effectiveness. Service capabilities include training programs and technical support accessible via phone and online support center.

Medical Positioning, Inc., founded in 1988 and headquartered in Lenexa, Kansas, manufactures specialized positioning and examination tables for diagnostic imaging and cardiology procedures. The company designs ergonomic equipment supporting echocardiography, cardiac catheterization, ultrasound imaging, mammography, modified barium swallow studies, and stress testing. Core product lines include the EchoBed® series (EchoBed® X, Stress EchoBed®), UltraScan® Versa™ tables for general and gynecological ultrasound, VasScan Table™ X for vascular imaging, UltraMamm® for mammography and breast ultrasound, MultiView® Modified Barium Swallow Chair, and tilt tables (HUT®, RR HUT®) for syncope and bradycardia evaluation. The Cath Ergometer™ supports right heart catheterization procedures. Additional offerings include the GSPM™ Table for pain management and C-arm imaging, Ultra DBI™ and stereotactic breast biopsy tables, and the EchoTable™. Medical Positioning serves hospitals, imaging centers, research facilities, medical schools, and distributors nationally and internationally. Products are engineered for clinical precision and operator comfort, with specialized positioning capabilities for specific diagnostic protocols. The company maintains direct sales and support operations in the United States.

Nano-X Imaging Ltd is a medical imaging company specializing in digital tomosynthesis and AI-driven diagnostic solutions. The company develops and markets FDA-cleared and CE-marked imaging systems featuring proprietary cold cathode X-ray technology. Primary product lines include Nanox.ARC and Nanox.ARC X, both digital multi-source 3D tomosynthesis systems designed for advanced radiographic visualization. Nanox.AI solutions provide FDA-cleared artificial intelligence capabilities targeting asymptomatic disease detection across cardiac, bone, and liver pathology. The platform leverages Nanox.SOURCE, a silicon-based, low-voltage, nano-scale cold cathode using field-emission technology to generate X-ray electron streams. Nanox.MARKETPLACE is a cloud-based diagnostic platform connecting imaging providers and facilities globally. The company serves hospital systems, imaging centers, and outpatient facilities, with collaborations including Varex, CSEM, Vieworks, NHS, Oxford University, and others. Products address radiography, tomosynthesis, and AI-assisted diagnostics. The company maintains a clinically driven approach with validation from academic radiologists and deployment across multiple healthcare settings.

Vomark Technologies is a US-based distributor and service provider specializing in new, refurbished, and certified pre-owned diagnostic ultrasound equipment and transducers. Founded approximately 20 years ago with headquarters in Wheeling, IL, and global offices in Europe and the U.S., Vomark serves hospitals, private practices, biomedical engineers, and global distributors worldwide. The company stocks over 1,000 ultrasound probes and has sold more than 2,500 systems, primarily from leading OEM manufacturers including GE, Philips, Siemens, Mindray, Canon/Toshiba, and SonoSite. Product offerings include general ultrasound systems, portable/point-of-care ultrasound devices, cardiac/echocardiography systems, obstetric/gynecology ultrasound, vascular systems, and musculoskeletal/needle-guidance equipment. Vomark also supplies replacement transducers and parts across all major brands. Core services include system and probe repair, equipment refurbishment, lease and rental options, equipment life-cycle management, and post-sale training. The company is an IAMERS member and Dotmed Top 100 certified specialist, operates under FDA oversight, and maintains ISO compliance. Clients include prominent institutions such as New York Presbyterian, Johns Hopkins Medicine, and Advocate Health Care.

Cleerly is an AI-driven software platform that enhances coronary CT angiography (CCTA) analysis for comprehensive coronary artery disease (CAD) assessment. The platform delivers quantitative, clinically actionable insights through automated 3D modeling of coronary arteries, plaque detection and characterization, stenosis measurement, and ischemia likelihood determination. Cleerly's core offerings include: AI-powered CAD analysis with 3D arterial reconstruction; plaque phenotyping (soft, fibrous, calcified); stenosis quantification in 2D and 3D; ischemia assessment via the proprietary Cleerly ISCHEMIA algorithm; and serial scan comparison (Cleerly COMPARE) for longitudinal CAD tracking. The platform integrates with PowerScribe for streamlined reporting workflows. Clinical validation includes the prospective CREDENCE trial (868 invasive FFR measurements) demonstrating superior diagnostic accuracy versus FFRCT and stress testing, and post-hoc PACIFIC study analysis showing Cleerly ISCHEMIA as the only non-invasive test prognostic of major adverse cardiac events. The solution targets cardiologists, interventional radiologists, and cardiac imaging centers seeking to reduce unnecessary invasive procedures and improve diagnostic confidence. The company supports commercial insurance reimbursement and provides web-based access to the platform. Designed for hospital and outpatient cardiac imaging workflows.

SCHILLER Americas is a cardiopulmonary diagnostic device manufacturer and solutions provider with 50 years of innovation in medical diagnostics. The company specializes in electrocardiography (EKG), lung function testing, patient monitoring systems, and diagnostic station equipment. Their product portfolio includes EKG devices, the DS-20 Diagnostic Station, lung function testing systems (including the TREMOFLO), and multiparameter patient monitoring solutions. SCHILLER serves multiple market segments: general practice clinics, hospitals, specialized lung function laboratories, and government distributors. The company emphasizes integration of device hardware, clinical software, and ergonomic user interface design under their "Art of Diagnostics" philosophy. They offer service solutions, equipment trials (SCHILLER Trial Program), and ADA-compliant device options to support accessible patient care. Based in Doral, Florida, SCHILLER Americas operates as the North American division of the SCHILLER Group, a globally recognized medical device manufacturer. Their solutions are deployed across primary care, acute care, pulmonary specialty, and occupational health settings.

Withings is a leading French connected health company founded in 2008, specializing in consumer-grade medical devices that combine clinical accuracy with elegant design. The company manufactures and distributes a comprehensive ecosystem of FDA-cleared and clinically validated health monitoring devices including smart scales with body composition analysis, hybrid smartwatches with built-in ECG and cardiac monitoring capabilities, connected blood pressure monitors, sleep tracking systems, and innovative devices like Body Scan (advanced body composition analysis), U-Scan (toilet-embedded urine analysis), and BeamO (portable home health station). All products integrate with the Withings Health Mate app and cloud platform for continuous health data aggregation and insights. Withings serves both B2C consumers and B2B healthcare providers globally through Withings Health Solutions, enabling remote patient monitoring, clinical research, and population health management. The company operates offices in Issy-les-Moulineaux (France), Boston, and Hong Kong, serving over 40 countries with devices recognized for medical-grade accuracy and accessibility.

Beijing Konted Medical Technology Co., Ltd. is a specialized manufacturer of handheld wireless ultrasound probes and systems, integrating R&D, production, sales, and after-sales service. The company produces over 30 product models of portable ultrasound transducers operating across frequency ranges of 2.2–24 MHz, serving medical professionals in 186 countries. Konted's product portfolio includes multipurpose single-probe systems, dual-head interchangeable probes, and specialty probes for cardiac, OB/GYN, ophthalmic, and abdominal applications. Offerings span black-and-white and color Doppler imaging, linear and convex transducer geometries, and veterinary ultrasound. The company serves primary care, emergency medicine, critical care, orthopedic/musculoskeletal, vascular intervention, anesthesia, aesthetics, plastic surgery, and ultrasound training markets. Recent product innovations include AI-powered facial ultrasound linear probes (18–24 MHz) for cosmetic applications and vein-finder devices. Konted provides ODM/OEM customization including software development, branded probe design, and custom packaging. Machine failure rates are reported below 1%, with over 100,000 doctors worldwide using their ultrasound systems. The company maintains partnerships with medical research institutions and universities for clinical validation and product development.

ImaCor Inc develops hemodynamic ultrasound systems for critical care settings, with primary focus on transesophageal echocardiography (TEE) for ICU, cardiac surgery, surgical/trauma, and intensive care units. The company's Hemodynamic Ultrasound platform enables direct visualization of cardiac filling and function over time to assess and guide interventions for critically ill patients. Core products include the Zura Handheld device and ClariTEE Probe, deployed via the proprietary hTEE 3-Step Method. This method combines gold-standard transesophageal echo practices with critical care protocols, allowing visualization of transgastric short axis, midesophageal four chamber, and SVC views. Clinical evidence indicates hTEE made direct therapeutic impact in 66% of patients and improved hemodynamics in 80% of cases. Primary clinical applications include fluid management and preload assessment, cardiac surgery support, trauma resuscitation, LVAD (left ventricular assist device) monitoring, and differentiation of cardiac tamponade from other causes of hemodynamic compromise. The company serves surgeons, intensivists, nurse practitioners, and trauma program managers across CVICU, SICU, MICU, and ED settings. ImaCor provides comprehensive educational support including whiteboard lessons, learning modules, case studies, peer-reviewed evidence, and 24/7 technical support. The platform addresses critical gaps in bedside cardiac assessment beyond traditional indirect methods such as blood pressure, lactate, and cardiac output monitoring.

Danlee Medical Products, Inc. is a women-owned, FDA-regulated manufacturer and distributor of cardiology equipment, supplies, and consumables. For over 25 years, the company has served as a one-stop source for healthcare facilities, medical offices, and supply companies, specializing in products for EKG/ECG testing, Holter monitoring, stress testing, echo/ultrasound, blood pressure monitoring, and vital sign assessment. The company manufactures customized hook-up kits for event recording and Holter monitor testing, and distributes a comprehensive catalog including ECG electrodes (including their proprietary Fantabstic® Resting Tab Electrode #3000), abrasive skin prep pads (Scrubbies®), chart paper, patient monitor cables, leadwires, stethoscopes, pulse oximeters, blood pressure cuffs, examination gloves, and related accessories. Danlee is an authorized distributor of major brands including 3M, Ambu, Burdick, Cardiac Science, ConMed, Dynarex, Edan USA, GE Healthcare, Medtronic, Mortara, Philips, Schiller, and Welch Allyn. The company operates a full e-commerce platform with fast order processing, secure purchasing, archived order history, and same-day customer service support. Danlee maintains regulatory compliance as an FDA-regulated entity and is recognized as a nationally certified women-owned business enterprise. Products serve hospitals, cardiology clinics, ambulatory surgery centers, and medical supply companies across the U.S. and globally.

ACIST Medical Systems, a subsidiary of the Bracco Group, manufactures diagnostic and interventional cardiology equipment for catheterization laboratories. The company specializes in contrast delivery systems, intravascular imaging (IVUS), and physiological assessment platforms used in coronary and peripheral interventions. ACIST's core product lines address three clinical domains: angiography (contrast management), imaging (high-definition intravascular ultrasound), and physiology (fractional flow reserve and pressure-derived assessments). The ACIST CVi contrast delivery system has been used in over 30 million clinical cases globally. The ACIST HDi represents the first high-definition IVUS system indicated for both coronary and peripheral vasculature. The ACIST RXi system, paired with Navvus II MicroCatheters, enables physiological assessment of complex coronary artery disease using standard 0.014-inch guidewires. Recently launched is the ACIST dPR algorithm, a non-hyperemic alternative for functional assessment. ACIST also markets the ACIST Pro diagnostic system in Europe. The company serves interventional cardiologists, cardiac surgeons, and interventional radiologists in hospitals and ambulatory cath labs. ACIST maintains manufacturing and service operations in Eden Prairie, Minnesota (global headquarters), with additional offices in Pleasanton, California; Heerlen, Netherlands; and Tokyo, Japan. The company provides clinical education, regulatory compliance support, consumables distribution, and 24/7 technical support. Products are cleared for use in the United States and hold CE marking in Europe.

Boston Scientific Corporation is a global medical device manufacturer serving multiple clinical specialties including cardiology, urology, gastroenterology, interventional radiology, electrophysiology, neurology, pain management, vascular surgery, and structural heart disease. The company manufactures and distributes a broad portfolio of minimally invasive medical devices, including cardiac rhythm management systems, interventional cardiology devices, electrophysiology catheters and mapping systems, spinal cord stimulation systems for pain management, urological devices, endoscopy and visualization systems, defibrillators, and interventional oncology equipment. Boston Scientific operates a healthcare professional portal providing online training through EDUCARE, e-commerce ordering, reimbursement resources, and comprehensive customer support with specialty-specific representative contact networks. The organization serves hospitals, ambulatory surgery centers, and healthcare professionals across the United States through direct sales and support teams organized by medical specialty. Products undergo rigorous regulatory compliance (FDA 510(k), international certifications) and the company emphasizes quality assurance and product safety as core organizational values. Customer care is available via a dedicated U.S. customer service line, with extended business hours Monday–Friday.

Convergent Imaging Solutions develops advanced image fusion and nuclear medicine software solutions for healthcare facilities. The company's flagship product, UniSyn MI™ software, provides comprehensive image fusion capabilities across multiple modalities including PET/CT, SPECT/CT, and PET/MR imaging. UniSyn MI supports local, remote, and hybrid deployment models with seamless PACS integration and configurable viewing and processing options. The software serves four primary clinical specialties: oncology (diagnosis, staging, recurrence detection, and treatment response evaluation), general nuclear medicine (planar, gated, and dynamic imaging analysis), cardiology (leveraging partnerships with Cedars-Sinai for cardiac processing), and neurology (neuroradiology imaging). The company also provides radiopharmaceutical dosimetry solutions for theranostic applications including metastatic neuroendocrine tumors, differentiated thyroid cancer, metastatic prostate cancer, and primary/metastatic liver disease. Convergent Imaging Solutions emphasizes workflow optimization, customizable solutions tailored to individual facility needs, and dedicated expert support. The company has received FDA 510(k) clearance for its MRT Dosimetry module. Based in Ottawa, Ontario, Canada, the company supports radiology and nuclear medicine professionals globally, serving as a workflow-optimized software provider for precision diagnostic imaging.

Canon Medical Diagnostics Corporation (Canon Medical Systems Corporation) is a global leader in diagnostic medical imaging equipment, headquartered in Ōtawara, Tochigi, Japan. With heritage dating to 1930 and pioneering innovations including the world's first commercial MRI system, the company delivers comprehensive diagnostic imaging solutions across CT, MRI, ultrasound, X-ray, angiography, and molecular imaging modalities. Canon Medical's product portfolio includes the Aquilion series of CT scanners, Vantage MRI systems, Aplio ultrasound platforms, and advanced X-ray/fluoroscopy systems. The company integrates AI-enhanced imaging, noise-reduction technologies, and portable/compact models to support clinical workflows across cardiology, oncology, stroke, sports medicine, and women's health. Canon Medical also provides Healthcare IT solutions including advanced visualization platforms (Vitrea), PACS integration, and AI-powered automation platforms for clinical image analysis. Under the 'Made for Life' philosophy, the company emphasizes patient-centric design, interoperability (DICOM/IHE compliance), and comprehensive service and support offerings for hospitals, imaging centers, and healthcare institutions globally.

Medispec Puerto Rico is a medical equipment distributor, rental, and service provider operating for over 10 years in the Caribbean region. The company specializes in supplying advanced diagnostic, surgical, and specialty medical equipment across multiple clinical disciplines including Ophthalmology, Radiology, Cardiology, Urology, Orthopedics, ENT, Neurosurgery, and Pain Management. Medispec maintains partnerships with leading global manufacturers (Zeiss, Genoray, Esaote, Canon, NSK, Nanosonics, and others) and offers comprehensive solutions covering diagnostic imaging systems, surgical microscopes, ultrasound equipment, sterilization systems, and clinical monitoring devices. The company emphasizes integrity, quality, and customer support through sales, equipment rental, and technical servicing for hospital systems and specialty practices throughout Puerto Rico.

Hamamatsu Photonics K.K. is a global leader in optical and photonic technologies with significant presence across France, Belgium, Switzerland, and Spain through its subsidiary Hamamatsu Photonics France, established in 1985. The company operates as a comprehensive supplier of advanced imaging and photonic solutions for medical, scientific research, and industrial applications. Core product portfolio encompasses over 15,000 items including scientific cameras (CCD/CMOS, InGaAs), optical sensors, photodiodes, light sources, laser systems, and spectroscopy equipment. Specialized medical applications include X-ray imaging systems, endoscopy visualization systems, and diagnostic imaging platforms. The company also supplies optoelectronic components, miniaturized spectrometers, and particle physics detectors for research institutions and healthcare facilities. With 80+ technical experts, Hamamatsu provides customized support, pilot-line manufacturing services, and rapid distribution across European and Mediterranean markets, emphasizing technical expertise and logistics efficiency.

Onyx Healthcare USA is an FDA-registered, ISO 13485-certified medical technology company headquartered in Orange, California, with manufacturing operations in New Taipei City, Taiwan. With over 20 years of specialized experience, Onyx designs and manufactures medical-grade computing solutions and AI-ready platforms for healthcare providers, medical device manufacturers, and integrators. The company offers comprehensive OEM/ODM services, including custom medical device design, rapid prototyping, and production of UL 60601-1 certified computing systems. Product portfolio encompasses medical PCs, slim medical panel PCs, all-in-one workstations, bedside terminals, mobile computing carts with hot-swap batteries, medical tablets, medical displays, single-board computers, and accessories. Onyx specializes in AI-accelerated edge computing platforms featuring NVIDIA and Intel processors, supporting real-time medical imaging, surgical applications, and clinical inference. Additional offerings include hospital IT services, telemedicine solutions, mobile nursing stations, patient engagement systems, and the proprietary Orion Hospital IT Management Software. The company serves North American and Latin American healthcare markets with a focus on quality, regulatory compliance, and extended product longevity.

DESKi develops HeartFocus, an FDA-cleared AI-powered ultrasound software platform that enables clinical-grade cardiac imaging (echocardiography) across diverse care settings without requiring specialized training or dedicated echo labs. The platform combines real-time 3D guidance, on-image AI overlay, auto-recording with quality validation, and live reference examples to help primary care clinicians, nurses, emergency departments, and cardiology teams acquire all ten standard echocardiographic views at diagnostic quality. HeartFocus integrates with DICOM/PACS systems and maintains HIPAA compliance. Clinical evidence published in JACC: Advances demonstrates that novice users, including nurses without prior ultrasound experience, achieved diagnostic-quality imaging across 100% of patients. The company targets primary care, acute care, cardiology, and medical education segments. DESKi has partnered with Butterfly Network for US commercial launch and offers the POCUS HeartFocus Certification—a first-of-its-kind program for AI-guided cardiac imaging. The solution addresses critical gaps in cardiac imaging access, particularly in rural and underserved communities, and supports scalability of cardiac care delivery across the care continuum.

YorLabs is a medical device manufacturer specializing in advanced diagnostic imaging solutions for interventional cardiology and electrophysiology procedures. The company develops ultraportable, handheld intracardiac echocardiography (ICE) systems powered by artificial intelligence. YorLabs' flagship ICE platform features a zero-footprint design, single-operator controls, and wireless connectivity to streamline image-guided therapy workflows. The system addresses critical inefficiencies in existing ultrasound platforms by reducing cognitive overload, procedural complexity, and workflow delays while lowering barriers to device adoption in interventional settings. Founded in 2015 and based in Beaverton, Oregon, YorLabs combines expertise from major technology and healthcare firms to deliver portable diagnostic imaging with enhanced accuracy and clinical usability.

BTL Industries is a global manufacturer of clinically proven medical and aesthetic equipment, operating since 1993 with headquarters in Prague and locations across 90+ countries. The company specializes in non-invasive therapeutic solutions for aesthetic medicine, rehabilitation and orthopaedics, cardiology and pulmonology, and advanced robotic medical systems. BTL's product portfolio encompasses body shaping and skin tightening devices, electrotherapy and ultrasound therapy systems, high-intensity laser therapy, cryotherapy, spinal decompression, cardiac monitoring and stress testing equipment, spirometry systems, and robotic rehabilitation solutions (R-GAIT, R-TOUCH, R-LEAD brands). The company serves diverse healthcare settings including small medical offices, multidisciplinary medical centers, hospitals, aesthetic clinics, and wellness centers. With approximately 3,700–4,000 employees including 500 engineers, BTL emphasizes clinical validation, technical reliability, comprehensive training programs, and after-sales support as core differentiators in the global medical device market.

Viz.ai is an AI-powered care coordination platform that leverages over 50 FDA-cleared algorithms to analyze medical imaging data and detect suspected diseases in real time. The company's flagship product, Viz.ai One®, autodetects conditions across multiple therapeutic areas including neurovascular disease, vascular conditions, cardiac imaging, trauma, and general radiology. The platform integrates specialized suites—Viz Neuro, Viz Cardio, Viz Vascular, Viz Trauma, and Viz Radiology—designed to accelerate diagnosis, streamline clinical workflows, and facilitate faster treatment decisions in acute care settings. Deployed in over 1,700 hospitals and health systems across the U.S. and Europe, Viz.ai's technology processes CT scans, EKGs, echocardiograms, and other imaging modalities to deliver automated assessments and real-time alerts to clinicians via mobile and desktop devices. The platform also supports life sciences partnerships with pharmaceutical and medical device companies for clinical trial optimization and disease-specific research applications.

Revvity, Inc. is a comprehensive life science solutions provider serving academia, pharmaceutical, biotech, clinical laboratories, contract research organizations, and healthcare professionals globally. The company operates across the drug discovery-to-diagnostics continuum, delivering integrated workflows in translational multi-omics, biomarker identification, imaging, screening, detection, diagnosis, and informatics. Product portfolio includes high-content screening instruments (Opera Phenix, EnVision plate readers), optical imaging systems (IVIS), cell analysis instruments (Cellometer), sample preparation equipment (Omni Bead Ruptor Elite homogenizers), and laboratory automation (Fontus workstations, LabChip systems). Reagent brands encompass BioLegend antibodies and flow cytometry reagents, AlphaLISA and SureFire immunoassays, HTRF TR-FRET assays, Dharmacon RNAi and CRISPR tools, and custom oligonucleotide synthesis. Representative diagnostic and clinical service offerings include newborn screening (33M+ annual screens), immunodiagnostics via EUROIMMUN solutions (85M+ blood samples analyzed), infectious disease serology, TB testing (T-SPOT.TB, 20M+ tested since 2002), reproductive health solutions (maternal/prenatal testing, cell-free DNA analysis, preeclampsia management), and clinical genomics services (300M+ tests performed). Licensing portfolio covers gene expression, editing, and viral vector technologies including LentiBOOST and Pin-point base editing platforms. Revvity serves 94% of top 50 global pharma companies, maintains ~11,000 employees worldwide, and operates on-site manufacturing, viral vector engineering, preclinical oncology services, and clinical testing. Regulatory presence includes FDA and CE approvals across diagnostics and instruments. The company integrates acquisition-driven growth with organic R&D, supporting discovery through clinical deployment across life science workflows.

Ontact Health Co., Ltd. develops SONIX Health, an FDA-cleared (510(k) K240645) AI-powered echocardiography analysis workstation designed to automate cardiac ultrasound interpretation and measurement. The solution performs fully automated analysis of 81 diagnostic parameters with 98% image recognition accuracy and 91% measurement accuracy, eliminating the need for ECG input by automatically detecting heart cycles via valve motion analysis. SONIX Health operates as vendor-neutral software compatible with multi-vendor echocardiography equipment, deployable on-premise or cloud-based without requiring high-specification hardware. The platform streamlines workflow through one-touch analysis from imaging to report generation, reducing clinician workload and examination wait times while supporting training applications. The company emphasizes clinical validation through peer-reviewed publications in cardiovascular imaging journals and demonstrated deployment in hospital environments across multiple geographies. Target markets include cardiac diagnostic centers, hospital ultrasound departments, and training programs seeking to standardize and accelerate echocardiographic assessment.

KeeboMed is an FDA-registered distributor and retailer of ultrasound equipment, probes, accessories, and related medical supplies for both human and veterinary medicine. The company specializes in used, refurbished, and new ultrasound systems from major manufacturers including Chison, GE, Philips, SonoSite, BK Medical, Sonoscape, Toshiba, and Mindray. Product portfolio includes portable ultrasound machines with color Doppler and 4D capabilities, compatible transducer probes for all major platforms, ultrasound accessories (carts, gels, batteries, bags), and veterinary ultrasound equipment. Secondary offerings include surgical sutures (PDS, PGA, nylon, silk, polyester, catgut), personal protective equipment (masks, gowns, goggles, coveralls), anesthesia equipment, vaporizers, orthopedic surgical implants and instruments (bone plates, drills, saws), and patient monitors. KeeboMed serves clinics, hospitals, veterinary practices, and individual practitioners seeking cost-effective equipment solutions. The company offers 60-day return policies, flexible financing options (ClickLease, Partners Capital), and customer support. With nearly 10,000 five-star reviews and over 30,000 orders fulfilled in the past decade, KeeboMed positions itself as a trusted B2B and B2C medical equipment supplier. FDA registration and regulatory compliance indicated; specific 510(k) or ISO certifications not detailed on homepage.

BIOTRONIK is a multinational medical technology company headquartered in Berlin, Germany, specializing in implantable cardiac devices and neuromodulation systems. Founded in 1963, BIOTRONIK develops and manufactures advanced solutions for cardiac rhythm management, including pacemakers, implantable cardioverter-defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices. The company pioneered remote patient monitoring with BIOTRONIK Home Monitoring, the world's first telemedicine system for cardiac implant follow-up (launched 2000). Additional offerings include spinal cord stimulation systems for chronic pain management and electrophysiology tools for arrhythmia treatment. With manufacturing facilities in Germany, the United States, and Switzerland, R&D centers across North America, Europe, and Singapore, and presence in over 100 countries, BIOTRONIK has implanted more than 19 million devices globally. The company emphasizes digitally-driven patient monitoring, AI-enabled diagnostics, and remote care solutions to improve clinical outcomes and patient quality of life.

Medistim ASA is a Norwegian medical device manufacturer headquartered in Oslo, with 40 years of innovation in surgical quality assurance. The company is a global leader in transit-time flow measurement (TTFM) and high-frequency ultrasound imaging systems for intraoperative assessment. Medistim manufactures three primary product lines: MiraQ Cardiac (combining ultrasound imaging and TTFM for cardiac surgery), MiraQ Vascular (designed for vascular and transplant surgery), and MiraQ Ultimate (dual-purpose system for both cardiac and vascular procedures). These systems enable surgeons to evaluate graft patency, anastomotic quality, and vessel integrity in real time during cardiac, vascular, and transplant procedures. The company serves hospitals and surgical centers globally through regional distribution partners and direct subsidiaries in the USA, UK, Germany, Norway, Spain, Sweden, Japan, and other countries. Medistim products are supported by clinical evidence from rigorous studies and are backed by comprehensive training, education, and technical support services. The company maintains manufacturing facilities in Horten, Norway, and provides customer service, accounts receivable support, and technical assistance through regional offices. Medistim emphasizes regulatory compliance, clinical rigor, and surgeon education through its EduQ online learning platform and Clinical Application Specialist training programs.

Oncovision is a Spanish-based medical imaging company specializing in innovative diagnostic and therapeutic imaging devices for oncology, radiology, surgery, and nuclear medicine. The company develops molecular imaging solutions focused on early cancer detection and treatment planning. Primary product lines include Mammi (breast PET imaging system for breast cancer diagnosis), Sentinella (intraoperative imaging system for surgical guidance), WProbe (portable probe device for accurate, practical imaging applications), and CaremiBrain (neuroimaging application for Alzheimer's disease diagnosis). The company serves surgeons, radiologists, oncologists, and nuclear physicians. Oncovision holds recognition as an innovative SME (PYME INNOVADORA) with validity through May 2027, indicating compliance with Spanish innovation standards. The company has received funding through Generalitat Valenciana's Fondos Plan Resistir Plus and is capitalized by Innvierte, an investment initiative of Spain's CDTI (Centro para el Desarrollo Tecnológico Industrial). The organization emphasizes innovation, commitment, excellence, and continuous improvement in molecular imaging technology for cancer diagnosis and treatment.

Aspen Medical Systems is a Puerto Rico-based distributor and service provider of diagnostic and cardiovascular ultrasound equipment. The company serves as the exclusive distributor for Alpinion Medical Systems in Puerto Rico and the Caribbean region. Core product lines include general and Doppler ultrasound systems, fetal and vascular Doppler equipment, and Transcranial Doppler (TCD) systems sourced through strategic partnerships with global manufacturers including PARKS Medical Electronics, DWL Compumedics, and Cooper Surgical. The company operates an educational division providing ultrasound simulation systems, including the Volutracer OPUS high-definition ultrasound simulator, and anatomical models and imaging phantoms through partnerships with Kyoto Kagaku. Service capabilities include technical support, professional installation and configuration, preventive maintenance, service contracts, equipment repair, and clinical training. Aspen Medical targets specialist physicians, hospitals, clinics, and academic institutions across the Caribbean market, positioning itself on comprehensive technical support and implementation expertise rather than manufacturing.